20 results
424B4
PRFX
PainReform Ltd
17 Apr 24
Prospectus supplement with pricing info
4:14pm
a refund in the event that we do not sell an amount of securities sufficient to pursue our business goals described in this prospectus. In addition
F-1/A
PRFX
PainReform Ltd
15 Apr 24
Registration statement (foreign) (amended)
9:41am
sufficient to pursue our business goals described in this prospectus. In addition, because there is no escrow account and no minimum offering amount
F-1
PRFX
PainReform Ltd
1 Mar 24
Registration statement (foreign)
4:34pm
and investors in this offering will not receive a refund in the event that we do not sell an amount of securities sufficient to pursue our business goals
S-8
EX-99.1
setljrjwvd5 pi
16 Jul 21
Registration of securities for employees
4:31pm
20-F
2akkvvc
18 Mar 21
Annual report (foreign)
9:03am
6-K
EX-99.1
qrloa4
19 Jan 21
Extraordinary General Meeting of Shareholders
4:35pm
6-K
EX-99.1
bjga jtsy
6 Jan 21
PainReform Appoints Rita Keynan as Vice President of Pharmaceutical Operations
9:00am
424B4
bwh3fh9
2 Sep 20
Prospectus supplement with pricing info
4:09pm
F-1/A
q0nsakvpfwv
31 Aug 20
Registration statement (foreign) (amended)
6:06am
F-1/A
22xp5wa3bnf
24 Aug 20
Registration statement (foreign) (amended)
12:15pm
F-1/A
8vulm 0wq
10 Aug 20
Registration statement (foreign) (amended)
4:15pm
F-1/A
0v9pvjaxyetk yc9y8
5 Aug 20
Registration statement (foreign) (amended)
1:26pm
F-1
EX-10.1
3r35ifqc 8qb
30 Jun 20
Registration statement (foreign)
5:16pm
F-1
5juz3a2418ixc0
30 Jun 20
Registration statement (foreign)
5:16pm
DRS/A
mgfob3d93381hp 2wc
2 Jun 20
Draft registration statement (amended)
12:00am
DRS/A
yaehgu
12 May 20
Draft registration statement (amended)
12:00am
DRS
fjc 9eblawduur3
3 Feb 20
Draft registration statement
12:00am
- Prev
- 1
- Next